NYSE:SYK

Stryker (SYK) Stock Forecast, Price & News

$266.54

-7.01 (-2.56%)

(As of 09/27/2023 ET)

Compare

Today's Range: $263.15
▼
$274.92
50-Day Range: $273.41
▼
$299.72
52-Week Range: $201.39
▼
$306.93

Volume: 3.03 million shs
Average Volume: 1.31 million shs
Market Capitalization: $101.23 billion

P/E Ratio: 37.65
Dividend Yield: 1.13%
Price Target: $309.59

Stryker MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.69 Rating Score
Upside/Downside: 16.2% Upside
$309.59 Price Target
Short Interest: Healthy
1.04% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.95
Upright™ Environmental Score
News Sentiment: 1.20
Based on 10 Articles This Week
Insider Trading: Selling Shares
$1.45 M Sold Last Quarter
Proj. Earnings Growth: 10.32%
From $10.37 to $11.44 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.93 out of 5 stars

Medical Sector

43rd out of 976 stocks

Surgical & Medical Instruments Industry

8th out of 98 stocks

2.3

Analyst's Opinion

Consensus Rating
Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.69, and is based on 11 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $309.59, Stryker has a forecasted upside of 16.2% from its current price of $266.54.
Amount of Analyst Coverage
Stryker has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.04% of the float of Stryker has been sold short.
Short Interest Ratio / Days to Cover
Stryker has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Stryker has recently increased by 14.24%, indicating that investor sentiment is decreasing significantly.

4.2

Dividend Strength

Dividend Yield
Stryker pays a meaningful dividend of 1.05%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Stryker has been increasing its dividend for 29 years.
Dividend Coverage
The dividend payout ratio of Stryker is 42.37%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Stryker will have a dividend payout ratio of 26.22% next year. This indicates that Stryker will be able to sustain or increase its dividend.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Stryker has received a 60.46% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Protective clothing", "Synthetic bone grafts", "Surgery simulation software", "Medical laboratory equipment", and "Bone cement" products. See details.
Environmental Sustainability
The Environmental Impact score for Stryker is -0.95.

3.4

News and Social Media Coverage

News Sentiment
Stryker has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Stryker this week, compared to 7 articles on an average week.
Search Interest
Only 12 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
MarketBeat Follows
17 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 143% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,445,000.00 in company stock.
Percentage Held by Insiders
Only 5.90% of the stock of Stryker is held by insiders.
Percentage Held by Institutions
76.24% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Stryker are expected to grow by 10.32% in the coming year, from $10.37 to $11.44 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Stryker is 37.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.57.
Price to Earnings Ratio vs. Sector
The P/E ratio of Stryker is 37.65, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 135.57.
Price to Earnings Growth Ratio
Stryker has a PEG Ratio of 2.78. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Stryker has a P/B Ratio of 6.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Stryker (NYSE:SYK) Stock

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

SYK Price History

30 days | 90 days | 365 days | Advanced Chart

SYK Stock News Headlines

September 22, 2023 | marketbeat.com

Bulgaria to purchase US Stryker combat vehicles and related equipment

Bulgaria’s government has approved the purchase of U.S.-made Stryker combat vehicles to modernize the country’s land forces and bring them in line with NATO standards

September 12, 2023 | marketbeat.com

AMC Stock: The Horror Film Traders Keep Showing Up For (SYK)

Just as AMC’s profitability was starting to improve, the dilution train has once again derailed traders' hopes of a turnaround.

September 28, 2023 | UNKNOWN (Ad)

A Bio-Tech Stock That Has Been Growing Like Crazy!

Recent News for This One Bio-Tech Has Us All Getting Excited. Sign Up today And Learn More

September 11, 2023 | marketbeat.com

16 Top Robotics Companies to Get to Know in 2023 (SYK)

What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat.

August 30, 2023 | marketbeat.com

A Significant Reversal is in Sight for These 5 Med Tech Companies (SYK)

Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.

August 29, 2023 | marketbeat.com

5 Good Reasons it's Time to Buy High-Yield Dividend King 3M (SYK)

3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up

September 26, 2023 | finance.yahoo.com

Unveiling Stryker Corp (SYK)'s Market Leadership: A Comprehensive Analysis of Financial Growth ...

September 26, 2023 | finance.yahoo.com

Unveiling Stryker (SYK)'s Value: Is It Really Priced Right? A Comprehensive Guide

September 28, 2023 | UNKNOWN (Ad)

A Bio-Tech Stock That Has Been Growing Like Crazy!

Recent News for This One Bio-Tech Has Us All Getting Excited. Sign Up today And Learn More

September 21, 2023 | finance.yahoo.com

Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact

September 19, 2023 | finance.yahoo.com

If You Invested $1000 in Stryker a Decade Ago, This is How Much It'd Be Worth Now

September 19, 2023 | finance.yahoo.com

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

September 18, 2023 | finance.yahoo.com

Top Research Reports for NVIDIA, AMD, Stryker & Others

September 15, 2023 | finance.yahoo.com

Stryker's (SYK) New Camera Platform to Improve Surgery Outcomes

September 15, 2023 | finance.yahoo.com

Strength Seen in Lantheus Holdings (LNTH): Can Its 6.4% Jump Turn into More Strength?

September 14, 2023 | finance.yahoo.com

A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras

September 13, 2023 | finance.yahoo.com

Stryker (SYK) Gets FDA 501k Clearance for Pangea Trauma Systems

September 12, 2023 | msn.com

Stryker gets FDA clearance for Pangea Systems for bone fractures

September 12, 2023 | finance.yahoo.com

Stryker’s Pangea Systems Receive FDA Clearance

September 11, 2023 | finance.yahoo.com

Stryker (SYK): A Comprehensive Guide to its Fair Valuation

September 11, 2023 | finance.yahoo.com

Unpacking Stryker Corp (SYK)'s Market Leadership: A Deep Dive into Financial Metrics and ...

September 9, 2023 | finance.yahoo.com

Insider Sell: Group President Viju Menon Sells 5,000 Shares of Stryker Corp

September 7, 2023 | seekingalpha.com

Stryker Corporation (SYK) Wells Fargo Securities Healthcare Conference (Transcript)

September 5, 2023 | msn.com

B of A Securities Upgrades Stryker (SYK)

September 5, 2023 | news.yahoo.com

Bulgaria wants to negotiate $1.5 billion Stryker deal with US

September 5, 2023 | msn.com

BofA upgrades Strkyer to buy, sees it as a top stock for 2024

September 5, 2023 | benzinga.com

Stryker Bull Expects Upside For Medtech Stock In '24, Ortho To Be 'Higher For Longer'

See More Headlines

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Company Calendar

Ex-Dividend for 7/31 Dividend: 6/29/2023
Dividend Payable: 7/31/2023
Last Earnings: 8/03/2023
Today: 9/28/2023
Ex-Dividend for 10/31 Dividend: 9/28/2023
Next Earnings (Estimated): 10/30/2023
Dividend Payable: 10/31/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:SYK
CUSIP: 86366710
CIK: 310764
Web: www.strykercorp.com
Phone: (269) 385-2600
Fax: 269-385-1062
Employees: 51,000
Year Founded: 1941

Price Target and Rating

Average Stock Price Forecast: $309.59
High Stock Price Forecast: $345.00
Low Stock Price Forecast: $250.00
Forecasted Upside/Downside: +16.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.69
Research Coverage: 16 Analysts

Profitability

EPS (Most Recent Fiscal Year): $7.08
Trailing P/E Ratio: 37.65
Forward P/E Ratio: 25.70
P/E Growth: 2.78
Net Income: $2.36 billion
Net Margins: 13.92%
Pretax Margin: 16.22%
Return on Equity: 22.31%
Return on Assets: 10.21%

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.54
Quick Ratio: 0.84

Sales & Book Value

Annual Sales: $18.45 billion
Price / Sales: 5.49
Cash Flow: $11.20 per share
Price / Cash Flow: 23.80
Book Value: $43.91 per share
Price / Book: 6.07

Miscellaneous

Outstanding Shares: 379,780,000
Free Float: 357,371,000
Market Cap: $101.23 billion
Optionable: Optionable
Beta: 0.95

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Kevin A. Lobo (Age 58)
Chairman, CEO & Pres
Comp: $3.31M

Mr. Glenn S. Boehnlein (Age 61)
VP & CFO
Comp: $1.43M

Mr. Viju S. Menon (Age 55)
Group Pres of Global Quality & Operations
Comp: $1.05M

Mr. J. Andrew Pierce (Age 49)
Group Pres of MedSurg & Neurotechnology
Comp: $1.32M

Mr. Spencer S. Stiles (Age 46)
Group Pres of Orthopaedics & Spine
Comp: $1.28M

Mr. William E. Berry Jr. (Age 57)
VP & Chief Accounting Officer

Mr. Robert C. Cohen
CTO and VP of Global R&D - Joint Replacement

Mr. Alan Douville
VP, Chief Information Officer & Chief Information Security Officer

Mr. Jason Beach
VP of Investor Relations

Mr. Robert S. Fletcher (Age 52)
VP & Chief Legal Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?: 16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SYK shares.
View SYK analyst ratings or view top-rated stocks.
What is Stryker's stock price forecast for 2023?: 16 Wall Street analysts have issued 1 year target prices for Stryker's shares. Their SYK share price forecasts range from $250.00 to $345.00. On average, they predict the company's stock price to reach $309.59 in the next twelve months. This suggests a possible upside of 16.2% from the stock's current price.
View analysts price targets for SYK or view top-rated stocks among Wall Street analysts.
How have SYK shares performed in 2023?: Stryker's stock was trading at $244.49 at the beginning of 2023. Since then, SYK stock has increased by 9.0% and is now trading at $266.54.
View the best growth stocks for 2023 here.
When is Stryker's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our SYK earnings forecast.
How were Stryker's earnings last quarter?: Stryker Co. (NYSE:SYK) released its quarterly earnings data on Thursday, August, 3rd. The medical technology company reported $2.54 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.16. The medical technology company earned $5 billion during the quarter, compared to analysts' expectations of $4.83 billion. Stryker had a net margin of 13.92% and a trailing twelve-month return on equity of 22.31%. The company's revenue for the quarter was up 11.2% on a year-over-year basis. During the same period in the previous year, the company posted $2.25 earnings per share.
Read the conference call transcript.
How often does Stryker pay dividends? What is the dividend yield for Stryker?: Stryker declared a quarterly dividend on Wednesday, August 2nd. Stockholders of record on Friday, September 29th will be paid a dividend of $0.75 per share on Tuesday, October 31st. This represents a $3.00 annualized dividend and a yield of 1.13%. The ex-dividend date is Thursday, September 28th.
Read our dividend analysis for SYK.
What ETFs hold Stryker's stock?: ETFs with the largest weight of Stryker (NYSE:SYK) stock in their portfolio include iShares U.S. Medical Devices ETF (IHI), AdvisorShares Focused Equity ETF (CWS), 2ndVote Life Neutral Plus ETF (LYFE), 2ndVote Society Defended ETF (EGIS), Democratic Large Cap Core ETF (DEMZ), Global X Aging Population ETF (AGNG), Fidelity Disruptive Medicine ETF (FMED) and BlackRock Future Health ETF (BMED).
Is Stryker a good dividend stock?: Stryker (NYSE:SYK) pays an annual dividend of $3.00 per share and currently has a dividend yield of 1.04%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 42.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 26.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.
What guidance has Stryker issued on next quarter's earnings?: Stryker updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of $10.25-$10.45 for the period, compared to the consensus EPS estimate of $10.16. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?: 1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Stryker own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).
What is Stryker's stock symbol?: Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."
Who are Stryker's major shareholders?: Stryker's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.81%), State Street Corp (3.79%), Capital Research Global Investors (3.78%), Bank of New York Mellon Corp (1.71%), Geode Capital Management LLC (1.62%) and Bank Julius Baer & Co. Ltd Zurich (1.30%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, James Andrew Pierce, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Ronda E Stryker, Srikant M Datar, Timothy J Scannell, Viju Menon and William E Berry Jr.
View institutional ownership trends.
How do I buy shares of Stryker?: Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Stryker's stock price today?: One share of SYK stock can currently be purchased for approximately $266.54.
How much money does Stryker make?: Stryker (NYSE:SYK) has a market capitalization of $101.23 billion and generates $18.45 billion in revenue each year. The medical technology company earns $2.36 billion in net income (profit) each year or $7.08 on an earnings per share basis.
How many employees does Stryker have?: The company employs 51,000 workers across the globe.
Does Stryker have any subsidiaries?: The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
How can I contact Stryker?: Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The official website for the company is www.strykercorp.com. The medical technology company can be reached via phone at (269) 385-2600, via email at katherine.owen@stryker.com, or via fax at 269-385-1062.

This page (NYSE:SYK) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial